AI assistant
Sending…
PALISADE BIO, INC. — Director's Dealing 2014
May 7, 2014
35274_dirs_2014-05-07_b0eb8266-7062-47f6-be64-a756c7392e70.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2014-05-05
Reporting Person: OLDAKER WILLIAM CLYDE (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-05 | Common Stock | P | 14250 | $3.4999 | Acquired | 116939 | Direct |
| 2014-05-05 | Common Stock | P | 985 | $3.50 | Acquired | 985 | Indirect |
Footnotes
F1: Disclosing the purchase of 14,250 common shares on open market by Reporting Person.
F2: Disclosing purchase of 985 common shares by Reporting Person's son.
F3: The Reporting Person disclaims beneficial ownership of these securities.
More from PALISADE BIO, INC.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 11